News
Concarlo Is On A Mission To Rid The World Of Metastatic Breast Cancer
Join this webinar to hear from Concarlo’s CEO and CSO Dr. Stacy Blain and COO LisaMarie Casey as they discuss the science behind a remarkable breakthrough in the treatment of metastatic cancers.
The Cancer Moonshot: A 5 Year Review
Join our webinar to learn about the incredible progress that’s being made to achieve these goals and what is still on the horizon.
RESI Innovator’s Pitch Challenge Winner
Concarlo wins the Innovator’s Pitch Challenge at RESI Jan 2021!
Targeting p27Kip1 to Treat Drug-Resistance Cancer
Stacy Blain, PhD, Founder, CSO and CEO
US biotech start-up set to have huge impact on breast cancer treatment landscape
Click to read the Drug Discovery World article about Concarlo, also featured in their fall issue.
Concarlo: targeting proliferation and resistance in one go
Click to read the BioCentury Emerging Company Profile.
Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer
Click to read the Life Science Newswire press release.
TigerTalks in the City: How Genomics Are Driving Novel Therapies
Stacy was a panelist at Princeton Entrepreneurship Council’s popular panel discussion series. Click to learn more.
2019 Social Enterprise Conference
Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.
WE NYC Women in Tech Conference
Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.
Impact Journals: March 2019
Click here to download the manuscript: Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture
Proactive Investors Interview
At the 11th Annual Biotech Showcase in San Francisco
Women & Wealth Magazine: 18 Women to Watch in 2018
Features Dr. Stacy Blain, Co-Founder and Chief Scientific Officer, Concarlo Holdings
SUNY Downstate Medical Center Press Release
SUNY Downstate Startup Company Secures Over $1 Million in Seed Funding Investment for Advancement of Proprietary Cancer Companion Diagnostic Test
Impact Journals: Oncoscience May 2018
Click here to download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.
Molecular Cancer Research Journal: March 2018
Click here to download Stacy and Priyank’s article:
Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells
Student Visit from Edsnaps
Increasing diversity in the science technology engineering & mathematics (STEM) workforce.
Research Associate Sarah Teed, M.S. welcomes young students to learn more about Concarlo’s mission.